Showing results (1-10 of 2,336) with videos related to
Sort By:
Pageof 234
Clinical Lung Cancer|July 6, 2021
Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non-Small Cell Lung Cancer: Results From the Randomized OAK TrialShirish Gadgeel, Fred R Hirsch, Keith Kerr, et al.Clinical Lung Cancer|May 29, 2021
Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 InhibitorsJun Oyanagi, Yasuhiro Koh, Koichi Sato, et al.Clinical Lung Cancer|June 15, 2021
EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung CancerJose Luis Leal, Marliese Alexander, Malinda Itchins, et al.Clinical Lung Cancer|December 18, 2020
Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge ResectionYoshinori Handa, Yasuhiro Tsutani, Takahiro Mimae, et al.Clinical Lung Cancer|December 17, 2022
A Phase I, Open-Label, Dose Confirmation, Escalation, and Expansion Trial of BI 1810631 as Monotherapy in Patients With Advanced or Metastatic Solid Tumors With HER2 AberrationsJohn Heymach, Frans Opdam, Minal Barve, et al.Clinical Lung Cancer|January 13, 2023
Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World StudyLixian Ling, Hongjuan Zheng, Haiping Lin, et al.Clinical Lung Cancer|January 14, 2023
Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare DataHoward West, Xiaohan Hu, Su Zhang, et al.Clinical Lung Cancer|January 16, 2023
Pretreatment Platelet Count is a Prognostic Marker in Lung Cancer: A Danish Registry-based Cohort StudyBirgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, Anne Winther-LarsenClinical Lung Cancer|June 8, 2022
The Significance of Lymph Node Ratio and Total Lymph Nodes Examined in Determining the Indications of Adjuvant Radiation in pN2 Non-small Cell Lung CancerFan Zhu, Haoyu Wang, Hani AshamallaClinical Lung Cancer|June 21, 2022
Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET TrialVictor Moreno, Desamparados Roda, Joanna Pikiel, et al.Pageof 234